Literature DB >> 1358613

Visualization of posture-dependent cerebral blood flow in a patient with Takayasu's disease by means of 99mTc-HMPAO brain single photon emission tomography.

K Hayashida1, T Nishimura, Y Hirose, T Kaminaga, S Imakita, T Uehara.   

Abstract

A case of Takayasu's disease in a 22-year-old woman who complained of severe fainting attacks is presented. Bilateral obstruction of the cervical arteries was confirmed by digital subtraction angiography. Preoperative technetium-99m hexamethylpropylene amine oxime brain SPET in the sitting position showed bilateral hypoactivity in the temporoparietal areas. Subtraction brain SPET showed slightly increased activity in the lying position. The patient has had no fainting attacks since bypass surgery. Postoperative 99mTc-HMPAO brain SPET in the sitting position showed normal activity except in the right temporoparietal area. This area was filled in the lying position. 99mTc-HMPAO brain SPET is the only technique that can visualize the cerebral blood flow in any position, this capability deriving on the fact that the distribution of 99mTc-HMPAO in the brain is fixed in the first 2-3 min following injection. The use of both sitting and lying 99mTc-HMPAO brain SPET is very useful for detecting an abnormality (i.e. an inhomogeneous response due to the fall in perfusion pressure) that could not be seen if the cerebral blood flow were to be assessed only in the lying position.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1358613     DOI: 10.1007/bf00175866

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  9 in total

1.  Cerebral blood flow and oxygen consumption in man.

Authors:  N A LASSEN
Journal:  Physiol Rev       Date:  1959-04       Impact factor: 37.312

2.  Evaluation of vasospasm secondary to subarachnoid hemorrhage with technetium-99m-hexamethyl-propyleneamine oxime (HM-PAO) tomoscintigraphy.

Authors:  J P Soucy; D McNamara; G Mohr; F Lamoureux; J Lamoureux; S Danais
Journal:  J Nucl Med       Date:  1990-06       Impact factor: 10.057

3.  Natural history and classification of occlusive thromboaortopathy (Takayasu's disease).

Authors:  K Ishikawa
Journal:  Circulation       Date:  1978-01       Impact factor: 29.690

4.  Evaluation of cerebral collateral circulation by technetium-99m HM-PAO brain SPECT during Matas test: report of three cases.

Authors:  H Matsuda; S Higashi; I N Asli; M Eftekhari; J Esmaili; H Seki; S Tsuji; H Oba; K Imai; H Terada
Journal:  J Nucl Med       Date:  1988-10       Impact factor: 10.057

5.  Technetium-99m HM-PAO brain SPECT in epileptic patients before and during unilateral hemispheric anesthesia (Wada test): report of three cases.

Authors:  H J Biersack; D Linke; F Brassel; K Reichmann; M Kurthen; H F Durwen; B M Reuter; J Wappenschmidt; H Stefan
Journal:  J Nucl Med       Date:  1987-11       Impact factor: 10.057

6.  Survival and morbidity after diagnosis of occlusive thromboaortopathy (Takayasu's disease).

Authors:  K Ishikawa
Journal:  Am J Cardiol       Date:  1981-05       Impact factor: 2.778

7.  Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO).

Authors:  R A Holmes; S B Chaplin; K G Royston; T J Hoffman; W A Volkert; D P Nowotnik; L R Canning; S A Cumming; R C Harrison; B Higley
Journal:  Nucl Med Commun       Date:  1985-08       Impact factor: 1.690

8.  Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.

Authors:  R D Neirinckx; L R Canning; I M Piper; D P Nowotnik; R D Pickett; R A Holmes; W A Volkert; A M Forster; P S Weisner; J A Marriott
Journal:  J Nucl Med       Date:  1987-02       Impact factor: 10.057

9.  Technetium-99m HM-PAO stereoisomers as potential agents for imaging regional cerebral blood flow: human volunteer studies.

Authors:  P F Sharp; F W Smith; H G Gemmell; D Lyall; N T Evans; D Gvozdanovic; J Davidson; D A Tyrrell; R D Pickett; R D Neirinckx
Journal:  J Nucl Med       Date:  1986-02       Impact factor: 10.057

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.